Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide D1
![](/proxy_img/aHR0cHM6Ly93d3cuYWJlb21pY3MuY29tL3Byb2R1Y3RfaW1hZ2UucGhwP3Bob3RvZmlsZT1pbWFnZXMvMzItNDkwMi8xLmpwZw==.jpg)
Figure-1: Western Blot analysis of SNRPD1 Antibody: Anti- SNRPD1 Antibody was used at 0.4 µg/ml on Baculovirus expression system.
Conditionnement : 10ug
Figure-1: Western Blot analysis of SNRPD1 Antibody: Anti- SNRPD1 Antibody was used at 0.4 µg/ml on Baculovirus expression system.
Amount : | 10 µg |
Purification : | Greater than 80% as determined by SDS-PAGE. |
Content : | Concentration 0.1 mg/ml in sterile PBS |
Storage condition : | Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles. |
Alternative Name : | Small nuclear ribonucleoprotein Sm D1, Sm-D1, Sm-D autoantigen, snRNP core protein D1, SNRPD1, SMD1, SNRPD, HsT2456. |
Source : Sf9 insect cells. SNRPD1 Human Recombinant produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 14,306 Dalton. SNRPD1 is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques. SNRPD1 is a small nuclear ribonucleoprotein which is a member of the SNRNP core protein family. SNRPD1 may act as a charged protein scaffold to stimulate SNRNP assembly or strengthen SNRNP-SNRNP interactions via nonspecific electrostatic contacts with RNA. In the autoimmune disease systemic lupus erythematosus, antinuclear antibodies are developed with Sm specificity.
There are currently no product reviews |